您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Dovitinib lactate
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Dovitinib lactate
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Dovitinib lactate图片
CAS NO:692737-80-7
包装与价格:
包装价格(元)
10 mM * 1 mL in DMSO电议
5mg电议
10mg电议
50mg电议
100mg电议
200mg电议
500mg电议
1 g电议
5 g电议

产品名称
多韦替尼乳酸盐
CHIR-258 lactate
TKI-258 lactate
产品介绍
Dovitinib lactate (TKI258 lactate) 是多靶点的酪氨酸激酶抑制剂,抑制FLT3c-KitFGFR1/3VEGFR1/2/3PDGFRα/βIC50值分别为 1,2,8/9,10/13/8,27/210 nM。
生物活性

Dovitinib lactate (TKI258 lactate) is a multi-targeted tyrosine kinase inhibitor withIC50s of 1, 2, 8/9, 10/13/8, 27/210 nM forFLT3,c-Kit,FGFR1/3,VEGFR1/2/3andPDGFRα/β, respectively[1].

IC50& Target

FGFR3

9 nM (IC50)

FGFR1

8 nM (IC50)

VEGFR1

1 nM (IC50)

VEGFR2

13 nM (IC50)

VEGFR3

8 nM (IC50)

PDGFRα

27 nM (IC50)

PDGFRβ

210 nM (IC50)

FLT3

1 nM (IC50)

c-Kit

2 nM (IC50)

体外研究
(In Vitro)

Dovitinib potently inhibits the FGF-stimulated growth of WT and F384L-FGFR3-expressing B9 cells with IC50values of 25 nM. B9-MINV cells are resistant to the inhibitory activity of Dovitinib at concentrations up to 1 μM. Dovitinib inhibits cell proliferation of KMS11 (FGFR3-Y373C), OPM2 (FGFR3-K650E), and KMS18 (FGFR3-G384D) cells with IC50of values of 90 nM (KMS11 and OPM2) and 550 nM, respectively[1]. Treatment of SK-HEP1 cells with dovitinib results in G2/M cell cycle arrest, inhibition of colony formation in soft agar and blockade of bFGF-induced cell migration. Dovitinib inhibits basal expression and FGF-induced phosphorylation of FGFR-1, FRS2-α and ERK1/2[2].

体内研究
(In Vivo)

Dovitinib (10 mg/kg, 30 mg/kg, 60 mg/kg, p.o.) shows significant antitumor effect in the KMS11-bearing mice model, and the growth inhibition is 48%, 78.5%, and 94% in the 10 mg/kg, 30 mg/kg, and 60 mg/kg treatment arms, respectively, compared with the placebo-treated mice[1]. Dovitinib demonstrates significant antitumor and antimetastatic activities in HCC xenograft models. Dovitinib potently inhibits tumor growth of six HCC lines. Inhibition of angiogenesis correlates with inactivation of FGFR/PDGFR-β/VEGFR-2 signaling pathways. Dovitinib also causes dephosphorylation of retinoblastoma, upregulation of p-histone H2A-X and p27, and downregulation of p-cdk-2 and cyclin B1, which results in a reduction in cellular proliferation and the induction of tumor cell apoptosis[2].

Clinical Trial
分子量

482.51

性状

Solid

Formula

C24H27FN6O4

CAS 号

692737-80-7

中文名称

多韦替尼乳酸盐

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

DMSO : ≥ 30 mg/mL(62.17 mM)

*"≥" means soluble, but saturation unknown.

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM2.0725 mL10.3625 mL20.7250 mL
5 mM0.4145 mL2.0725 mL4.1450 mL
10 mM0.2072 mL1.0362 mL2.0725 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。